Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Retinal Disorders Therapy Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Age Related Macular Degeneration
  • 1.3.3 Diabetic Retinopathy
  • 1.3.4 Ocular Inflammatory Disease (Uveitis)
  • 1.3.5 Macular Hole
• 1.4 Market Segment by Application
  • 1.4.1 Global Retinal Disorders Therapy Market Share by Application (2019-2025)
  • 1.4.2 Hospitals
  • 1.4.3 Clinics
  • 1.4.4 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Retinal Disorders Therapy Market Size
  • 2.1.1 Global Retinal Disorders Therapy Revenue 2014-2025
  • 2.1.2 Global Retinal Disorders Therapy Sales 2014-2025
• 2.2 Retinal Disorders Therapy Growth Rate by Regions
  • 2.2.1 Global Retinal Disorders Therapy Sales by Regions 2014-2019
  • 2.2.2 Global Retinal Disorders Therapy Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Retinal Disorders Therapy Sales by Manufacturers
  • 3.1.1 Retinal Disorders Therapy Sales by Manufacturers 2014-2019
  • 3.1.2 Retinal Disorders Therapy Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Retinal Disorders Therapy Revenue by Manufacturers (2014-2019)
  • 3.2.2 Retinal Disorders Therapy Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Retinal Disorders Therapy Market Concentration Ratio (CR5 and HHI)
• 3.3 Retinal Disorders Therapy Price by Manufacturers
• 3.4 Key Manufacturers Retinal Disorders Therapy Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Retinal Disorders Therapy Market
• 3.6 Key Manufacturers Retinal Disorders Therapy Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Age Related Macular Degeneration Sales and Revenue (2014-2019)
  • 4.1.2 Diabetic Retinopathy Sales and Revenue (2014-2019)
  • 4.1.3 Ocular Inflammatory Disease (Uveitis) Sales and Revenue (2014-2019)
  • 4.1.4 Macular Hole Sales and Revenue (2014-2019)
• 4.2 Global Retinal Disorders Therapy Sales Market Share by Type
• 4.3 Global Retinal Disorders Therapy Revenue Market Share by Type
• 4.4 Retinal Disorders Therapy Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Retinal Disorders Therapy Sales by Application

6 United States

• 6.1 United States Retinal Disorders Therapy Breakdown Data by Company
• 6.2 United States Retinal Disorders Therapy Breakdown Data by Type
• 6.3 United States Retinal Disorders Therapy Breakdown Data by Application

7 European Union

• 7.1 European Union Retinal Disorders Therapy Breakdown Data by Company
• 7.2 European Union Retinal Disorders Therapy Breakdown Data by Type
• 7.3 European Union Retinal Disorders Therapy Breakdown Data by Application

8 China

• 8.1 China Retinal Disorders Therapy Breakdown Data by Company
• 8.2 China Retinal Disorders Therapy Breakdown Data by Type
• 8.3 China Retinal Disorders Therapy Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Retinal Disorders Therapy Breakdown Data by Company
• 9.2 Rest of World Retinal Disorders Therapy Breakdown Data by Type
• 9.3 Rest of World Retinal Disorders Therapy Breakdown Data by Application
• 9.4 Rest of World Retinal Disorders Therapy Breakdown Data by Countries
  • 9.4.1 Rest of World Retinal Disorders Therapy Sales by Countries
  • 9.4.2 Rest of World Retinal Disorders Therapy Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 ALLERGAN
  • 10.1.1 ALLERGAN Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Retinal Disorders Therapy
  • 10.1.4 Retinal Disorders Therapy Product Introduction
  • 10.1.5 ALLERGAN Recent Development
• 10.2 AbbVie
  • 10.2.1 AbbVie Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Retinal Disorders Therapy
  • 10.2.4 Retinal Disorders Therapy Product Introduction
  • 10.2.5 AbbVie Recent Development
• 10.3 Alimera Sciences
  • 10.3.1 Alimera Sciences Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Retinal Disorders Therapy
  • 10.3.4 Retinal Disorders Therapy Product Introduction
  • 10.3.5 Alimera Sciences Recent Development
• 10.4 Janssen Biotech
  • 10.4.1 Janssen Biotech Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Retinal Disorders Therapy
  • 10.4.4 Retinal Disorders Therapy Product Introduction
  • 10.4.5 Janssen Biotech Recent Development
• 10.5 Swedish Orphan Biovitrum
  • 10.5.1 Swedish Orphan Biovitrum Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Retinal Disorders Therapy
  • 10.5.4 Retinal Disorders Therapy Product Introduction
  • 10.5.5 Swedish Orphan Biovitrum Recent Development
• 10.6 Roche
  • 10.6.1 Roche Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Retinal Disorders Therapy
  • 10.6.4 Retinal Disorders Therapy Product Introduction
  • 10.6.5 Roche Recent Development
• 10.7 Bristol-Myers Squibb
  • 10.7.1 Bristol-Myers Squibb Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Retinal Disorders Therapy
  • 10.7.4 Retinal Disorders Therapy Product Introduction
  • 10.7.5 Bristol-Myers Squibb Recent Development
• 10.8 Genzyme
  • 10.8.1 Genzyme Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Retinal Disorders Therapy
  • 10.8.4 Retinal Disorders Therapy Product Introduction
  • 10.8.5 Genzyme Recent Development
• 10.9 Genentech
  • 10.9.1 Genentech Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Retinal Disorders Therapy
  • 10.9.4 Retinal Disorders Therapy Product Introduction
  • 10.9.5 Genentech Recent Development
• 10.10 OCULAR THERAPEUTIX
  • 10.10.1 OCULAR THERAPEUTIX Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Retinal Disorders Therapy
  • 10.10.4 Retinal Disorders Therapy Product Introduction
  • 10.10.5 OCULAR THERAPEUTIX Recent Development
• 10.11 Bausch & Lomb
• 10.12 UCBCares

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Retinal Disorders Therapy Sales Channels
  • 11.2.2 Retinal Disorders Therapy Distributors
• 11.3 Retinal Disorders Therapy Customers

12 Market Forecast

• 12.1 Global Retinal Disorders Therapy Sales and Revenue Forecast 2019-2025
• 12.2 Global Retinal Disorders Therapy Sales Forecast by Type
• 12.3 Global Retinal Disorders Therapy Sales Forecast by Application
• 12.4 Retinal Disorders Therapy Forecast by Regions
  • 12.4.1 Global Retinal Disorders Therapy Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Retinal Disorders Therapy Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Retina is a very sensitive and delicate part of human eye which is responsible for receiving and processing light to convert into neural signals and send to the brain for visual activity. The disorders related to retinal health include age-related macular degeneration, diabetic retinopathy, infectious retinitis, macular edema, macular hole, retinoblastoma, retinal degeneration, retinoschisis and uveitis etc. There are various types of retinal disorders but most of them cause visual symptoms.
In 2019, the market size of Retinal Disorders Therapy is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Retinal Disorders Therapy.

This report studies the global market size of Retinal Disorders Therapy, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Retinal Disorders Therapy sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
ALLERGAN
AbbVie
Alimera Sciences
Janssen Biotech
Swedish Orphan Biovitrum
Roche
Bristol-Myers Squibb
Genzyme
Genentech 
OCULAR THERAPEUTIX
Bausch & Lomb
UCBCares

Market Segment by Product Type
Age Related Macular Degeneration
Diabetic Retinopathy
Ocular Inflammatory Disease (Uveitis)
Macular Hole

Market Segment by Application
Hospitals
Clinics
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Retinal Disorders Therapy status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Retinal Disorders Therapy manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Retinal Disorders Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025